Cone-Rod Dystrophy, X-Linked, Type 1: Clinical Trials

1 trial for Cone-Rod Dystrophy, X-Linked, Type 1, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow Cone-Rod Dystrophy, X-Linked, Type 1: new trials by email Literature Review of Cone-Rod Dystrophy, X-Linked, Type 1 trials Research Report on Cone-Rod Dystrophy, X-Linked, Type 1

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Trial of Retinal Gene Therapy for X-linked Retinitis Pigmentosa Using BIIB112
BIIB112 - X-Linked Retinitis Pigmentosa
Phase 1 / Phase 2CompletedBiogen502017-03-082024-01-18

Interventions

Cotoretigene Toliparvovec (1)

Sponsors

Biogen (1)

Countries

United Kingdom (1)  ·  United States (1)

Results publications

PMID 32094925, PMID 36757689, PMID 38423215, PMID 40535564

NIH funding

2016 (1)